1.
CircRNA: a novel type of biomarker for cancer
by Zhang, He-da
Breast cancer (Tokyo, Japan), 2017-07-18, Vol.25 (1), p.1-7
2.
Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes
by Griffin, Simon J
Diabetologia, 2017-08-02, Vol.60 (9), p.1620-1629
3.
Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-contro...
by Vermeire, Séverine, Prof
The Lancet (British edition), 2016, Vol.389 (10066), p.266-275
4.
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials
by BAIGENT, Colin
The Lancet (British edition), 2013, Vol.382 (9894), p.769-779
5.
Superoxide Dismutases: Role in Redox Signaling, Vascular Function, and Diseases
by Fukai, Tohru
Antioxidants & redox signaling, 2011-09-15, Vol.15 (6), p.1583-1606
6.
COVID-19 – A vascular disease
by Siddiqi, Hasan K
Trends in cardiovascular medicine, 2021-01, Vol.31 (1), p.1-5
7.
Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice
by Knight, Jason S
Annals of the Rheumatic Diseases, 2015-12, Vol.74 (12), p.2199-2206
8.
Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study
by McInnes, Iain B
Annals of the rheumatic diseases, 2015-04, Vol.74 (4), p.694-702
9.
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes
by Zoungas, Sophia
Diabetologia, 2014-09-17, Vol.57 (12), p.2465-2474
10.
Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial
by Sabatine, Marc S., MD, MPH
The American heart journal, 2015, Vol.173, p.94-101
11.
Optical coherence tomography angiography: a review of current and future clinical applications
by Ang, Marcus
Graefe's archive for clinical and experimental ophthalmology, 2018-01-09, Vol.256 (2), p.237-245
12.
Nutcracker Phenomenon and Nutcracker Syndrome
by Kurklinsky, Andrew K., MD, MACP
Mayo Clinic proceedings, 2010, Vol.85 (6), p.552-559
13.
The effect of flavanol-rich cocoa on cerebral perfusion in healthy older adults during conscious resting state: a placebo controlled, crossover, acute trial
by Lamport, Daniel J
Psychopharmacology, 2015-06-07, Vol.232 (17), p.3227-3234
14.
Spectrum of Retinal Vascular Diseases Associated With Paracentral Acute Middle Maculopathy
by Chen, Xuejing
American journal of ophthalmology, 2015, Vol.160 (1), p.26-34.e1
15.
VP-002 Percutaneous Treatment of Mesenteric Vascular Disease
by Kilic, Harun
The American journal of cardiology, 2016, Vol.117, p.S41-S41
16.
Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease?
by Kralisch, S
Diabetologia, 2012-09-29, Vol.56 (1), p.10-21
17.
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
by Baigent, Colin
The Lancet (British edition), 2009, Vol.373 (9678), p.1849-1860
18.
Association of a difference in systolic blood pressure between arms with vascular disease and mortality: a systematic review and meta-analysis
by Clark, Christopher E, Dr
The Lancet (British edition), 2012, Vol.379 (9819), p.905-914
19.
Fluid Mechanics, Arterial Disease, and Gene Expression
by Tarbell, John M
Annual Review of Fluid Mechanics, 2014-01-03, Vol.46 (1), p.591-614
20.
Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study)
by Rothwell, PM
The Lancet (British edition), 2005, Vol.366 (9499), p.1773-1783
